Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Local Paclitaxel Delivery for SFA Disease (IRRITAX)

This study has been completed.
Information provided by (Responsible Party):
University of Oklahoma Identifier:
First received: January 5, 2009
Last updated: December 19, 2013
Last verified: December 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2012
  Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)